Security record · archived quarter
VKTX
Viking Therapeutics, Inc. · Healthcare · Biotechnology
12Tracked holders
n/aΔ holders
5.57MShares held
$295.04MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 29.61K | $851,871 | n/a | n/a |
| Q2 2026 | 109 | +6 | 57.62M | $2.25B | +10 | −4 |
| Q1 2026 | 106 | -1 | 56.45M | $1.88B | +7 | −8 |
| Q4 2025 | 106 | +1 | 58.95M | $2.07B | +2 | −1 |
| Q3 2025 | 16 | -1 | 41.62M | $1.09B | +2 | −4 |
| Q2 2025 | 15 | 0 | 36.99M | $980.19M | +2 | −2 |
| Q1 2025 | 12 | +3 | 10.64M | $256.98M | +3 | n/a |
| Q4 2024 | 9 | -3 | 10.39M | $418.15M | n/a | −3 |
| Q3 2024 | 11 | -1 | 6.74M | $426.33M | n/a | −1 |
| Q2 2024 | 12 | n/a | 5.57M | $295.04M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.86M | n/a | $98.58M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Viking Global Investors ✦ | 1.35M | n/a | $71.80M | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 723.01K | n/a | $38.33M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 525.50K | n/a | $27.86M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 466.48K | n/a | $24.73M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passive) | 182.37K | n/a | $9.67M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 159.40K | n/a | $8.45M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 73.70K | n/a | $3.91M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 68.07K | n/a | $3.61M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | T. Rowe Price ✦ | 59.67K | n/a | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 53.68K | n/a | $2.85M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 39.84K | n/a | $2.11M | 0.0% | n/c | 1 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 9.80K shares, $318 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API